Navigation Links
Tennessee Breast Center Selects Sectra RIS/PACS
Date:10/1/2013

SHELTON, Connecticut, October 1, 2013 /PRNewswire/ --

Knoxville Comprehensive Breast Center (KCBC), a full-service breast health care practice, has recently signed an agreement with the international medical imaging IT company,Sectra  (STO: SECT B).  Under the agreement, KCBC will utilize Sectra breast imaging PACS and RIS to provide improved service to its referring physician community and patient population.

     (Logo: http://photos.prnewswire.com/prnh/20120601/537255)

With Sectra's solution, KCBC will offer its referring physicians the ability to order studies on-line to ensure prompt scheduling for their patients.  The KCBC staff will gain efficiencies via a unified system from image acquisition through report distribution.  

"Sectra was a logical choice for our practice," says the KCBC Administrator, Michelle Oglesby. "We wanted a system that provided full PACS viewing functionality for breast MRI and ultrasound, as well as mammography.  The logical hanging protocols and excellent toolset will allow us to continue to be the leader in breast health care in the Knoxville community."

Sectra Breast Imaging PACS is a web-based, multi-modality workstation featuring advanced diagnostic tools, including integrated CAD and reporting, that offers a single-system reading environment for mammographers.  All digital breast images, regardless of modality vendor, are automatically displayed in the same size with correct orientation and alignment, facilitating comparison of current and prior images.  

About Sectra

With more than 20 years in the business, Sectra develops and sells IT systems and services for radiology, women's health, orthopaedics and rheumatology. More than 1,400 hospitals, clinics and imaging centers worldwide use the systems daily, together performing over 70 million radiology examinations annually. This makes Sectra one of the world-leading companies within systems for handling digital radiology images. Sectra's systems have been installed in North America, Scandinavia and most major countries in Europe and the Far East. For more information, visit http://www.sectra.com

About Knoxville Comprehensive Breast Center

The Knoxville Comprehensive Breast Center comprises a staff of over 70 employees including 5 physicians specializing in breast care and utilizing digital mammographic machines, 10 ultrasound machines, a stereotactic table, 2 dedicated Breast MRI machines and a Digital Mobile Mammography Coach.  Founder and Medical Director, Dr. Kamilia Kozlowski has delivered exceptional breast care to women in the area since 1983. For more information, visit http://www.knoxvillebreastcenter.com

Contact:
Andrea Sowitch
Director of Marketing
Sectra North America
E-mail: Andrea.Sowitch@sectra.com
Phone: +1-203-925-0899 ext 268
http://www.sectra.com/medical    


'/>"/>
SOURCE Sectra North America Inc
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Bayer CropScience Breaks Ground on New Greenhouse For Cotton Research And Development in Memphis, Tennessee
2. Maryville, Tennessee Based Molecular Pathology Laboratory Network (MPLN) Celebrates 38th Annual Medical Laboratory Professional Week by Honoring Employees
3. Avon Foundation for Women, NIH, and the Center for Advancing Innovation Launch Start-Up Challenge to Advance Breast Cancer Biomedical Invention
4. MarketResearchReports.Biz: Companion Diagnostics Market (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma And Others) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019 - New Industry Report
5. FreeMyGenes.org and Facebook Campaign Launched to Raise Awareness of Fight to Make Genetic Testing for Breast and Other Cancers More Affordable and Accessible
6. Montclair Breast Center Introduces Online Breast Cancer Risk Quiz
7. Signal Genetics Announces Publication of BreastPRS™ Validation Study with Weill Cornell Medical College, New York
8. Research Shows That SurePure Technology Offers Alternative to Thermal Pasteurization of Human Breast Milk
9. CTI Reports Final Results from Cooperative Group and NCI-Sponsored Trial of Brostallicin in Patients with Metastatic Triple-Negative Breast Cancer
10. Novartis highlights new findings in advancing care for patients with 170 abstracts in breast, lung and blood cancers at ASCO and EHA
11. MacroGenics Announces Margetuximab (MGAH22) Phase 1 Data Presentation at ASCO; Initiates Phase 2 Clinical Study to Evaluate Activity of Margetuximab in Patients with Metastatic Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/16/2017)... , Feb. 16, 2017  Champions Oncology, Inc. ... the development and sale of advanced technology solutions and ... drugs, today announced the addition of new cohorts of ... These new models will expand Champions, product line in ... and neck cancer, AML, and non-small cell lung cancer ...
(Date:2/16/2017)... NEW YORK , Feb. 16, 2017 ... $7M Series B financing, adding an additional $3M from ... by Mesa Verde Venture Partners and other strategic partners ... directed towards further accelerating commercial adoption of their flagship ... test and expanding the Paradigm cancer registry. ...
(Date:2/15/2017)... , 15. Februar 2017  Trianni, Inc. ... Biotech, Inc. (Janssen) eine Lizenzvereinbarung über die Verwendung ... Klasse führenden Plattform für die Entdeckung monoklonaler Antikörper. ... ihr neuartiges chimäres Gensegmentdesign aus, das Janssen ... humanen Antikörpern bietet und das für die schelle ...
(Date:2/15/2017)... 15, 2017 Windtree Therapeutics, Inc. (Nasdaq: ... aerosolized KL4 surfactant therapies for respiratory diseases, will host ... at 8:00 AM EST on Thursday, February 16, 2017 ... program, the recently announced closing of a $10.5 million ... To participate in the live call and take ...
Breaking Biology Technology:
(Date:2/6/2017)... DENVER , Feb. 6, 2017 ... national security are driving border authorities to continue ... Acuity reports there are 2143 Automated Border Control ... Kiosks currently deployed at more than 163 ports ... between 2013 to 2016 achieving a combined CAGR ...
(Date:2/2/2017)... 2017   TapImmune, Inc. (NASDAQ: ... in the development of innovative peptide and gene-based ... and metastatic disease, announced today it has successfully ... a second clinical lot of TPIV 200, the ... The manufactured vaccine product will be used to ...
(Date:2/1/2017)... Massachusetts , February 1, 2017 IDTechEx ... events on emerging technology, announces the availability of a new report, ... Continue Reading ... ... in industrial and collaborative robots. Source: IDTechEx Report "Sensors for Robotics: ...
Breaking Biology News(10 mins):